BPA is actively taken up by cancer cells through L-type amino acid transporter 1, which is highly upregulated in several cancers [20], whereas BSH is typically used for malignant gliomas and accumulates in areas where the blood brain barrier is compromised by the cancer [21]. Here, SLC7A5 is linked to cancer.